TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 53 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,160 | +333.7% | 66,190 | -9.3% | 0.00% | – |
| Q2 2023 | $48,225 | -17.1% | 72,958 | 0.0% | 0.00% | – |
| Q1 2023 | $58,191 | -64.7% | 72,958 | 0.0% | 0.00% | – |
| Q4 2022 | $164,885 | +114.1% | 72,958 | +82.7% | 0.00% | – |
| Q3 2022 | $77,000 | -46.5% | 39,927 | +2.8% | 0.00% | – |
| Q2 2022 | $144,000 | -89.3% | 38,821 | -81.1% | 0.00% | – |
| Q1 2022 | $1,340,000 | -46.5% | 205,625 | -4.3% | 0.00% | – |
| Q4 2021 | $2,504,000 | -36.5% | 214,970 | +1.4% | 0.00% | -100.0% |
| Q3 2021 | $3,946,000 | -6.4% | 211,928 | +6.6% | 0.00% | 0.0% |
| Q2 2021 | $4,216,000 | +114.2% | 198,859 | +105.2% | 0.00% | – |
| Q1 2021 | $1,968,000 | -28.2% | 96,924 | -6.1% | 0.00% | -100.0% |
| Q4 2020 | $2,740,000 | – | 103,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |